Clinical Trials in Oslo, Oslo County
14 recruiting
Showing 1–14 of 14 trials
Recruiting
Phase 2
HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)
Chemotherapy EffectIntrahepatic Cholangiocarcinoma
Oslo University Hospital39 enrolled1 locationNCT06313203
Recruiting
Phase 2
Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
Melanoma Stage IV
Melanoma Institute Australia218 enrolled9 locationsNCT03340129
Recruiting
Phase 2
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
Parkinson's DiseaseParkinson Disease (PD)
Haukeland University Hospital100 enrolled11 locationsNCT07312110
Recruiting
Phase 2Phase 3
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Advanced Melanoma
Eikon Therapeutics740 enrolled77 locationsNCT06697301
Recruiting
Not Applicable
Early Support After Exposure to Trauma
Post Traumatic Stress Disorder
Norwegian Center for Violence and Traumatic Stress Studies360 enrolled21 locationsNCT06592677
Recruiting
Phase 1Phase 2
The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma
Multiple MyelomaSmoldering Multiple Myeloma
Oslo University Hospital20 enrolled1 locationNCT05841550
Recruiting
Intestinal Ischemia Biomarker in Patients With Chronic Mesenteric Ischemia
Crohn DiseaseCholelithiasisChronic Mesenteric Ischemia+1 more
Oslo University Hospital180 enrolled1 locationNCT06468774
Recruiting
Investigating Myocardial Remodelling in the Failing Human Heart
Heart Failure
Oslo University Hospital200 enrolled1 locationNCT05303896
Recruiting
Phase 3
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Prostate Cancer
Sven Löffeler980 enrolled18 locationsNCT05448547
Recruiting
Phase 2
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
NeuroblastomaNeuroblastoma Recurrent
Jakob Stenman24 enrolled5 locationsNCT04903899
Recruiting
Phase 2
NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma
Melanoma Stage IIIB-IV
Oslo University Hospital27 enrolled1 locationNCT06651151
Recruiting
Phase 2
Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
Alzheimer DiseaseCognitive Decline, Mild
Helse Stavanger HF200 enrolled6 locationsNCT06362707
Recruiting
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Sarcoma,Soft TissueEpithelioid Hemangioendothelioma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano100 enrolled21 locationsNCT06408441
Recruiting
Phase 3
DAPAgliflozin for Renal Protection in Heart Transplant Recipients
Kidney FailureHeart Transplant Failure
Oslo University Hospital430 enrolled6 locationsNCT05321706